CLLS Competitors & Alternatives
Compare Cellectis SA with similar stocks in the same industry
Biotechnology
CLLS
Main Stock$1.33
Tradestie Score
32
Market Cap
$330.07M
Revenue Growth
-0.6%
Analyst Upside
+262.8%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
|
$180.53M | - | 54 | Compare |
|
MCRB
Seres Therapeutics, Inc.
|
$1.41
|
$179.47M | - | 39 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.23
|
$154.27M | - | 41 | Compare |
|
FATE
Fate Therapeutics, Inc.
|
$1.34
|
$144.16M | - | 41 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.87
|
$133.50M | - | 31 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$31.67
|
$117.07M | - | 30 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$4.81
|
$114.01M | - | 57 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$30.62
|
$110.20M | - | 41 | Compare |
|
ATRA
Atara Biotherapeutics, Inc
|
$7.93
|
$101.48M | - | 51 | Compare |
More CLLS Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry